Over the past two decades, continued improvements in the understanding of HIV, chronic viral hepatitis, haematological oncology, NASH, inflammatory diseases and invasive fungal infections have led to the development of significant new treatments, with multiple therapeutic options now available in these disease areas. As a result, many patients are living longer and have an improved quality of life.

However, while much research at a basic science and clinical trial level is focused on drug discovery and evaluation, Gilead recognises that a key part of improving patient care in real terms is the development of approaches to diagnosis, treatment and education at a local practice level. Learnings from successful initiatives can be applied to other communities and/or replicated in other parts of the country, to provide practical solutions to current challenges across these specific therapy areas.

Aim of the Research Grants Program

The aim of the Research Grants Program is to support the development, exploration and implementation of best practice in enhancing patient care in the specific disease areas of:

  • HIV
  • Chronic viral hepatitis
  • Haematological oncology
  • NASH
  • Inflammatory diseases
  • Invasive fungal infections


Gilead Sciences Pty Ltd is proud to work in partnership with the Australian research and clinical community to provide opportunities for ongoing scientific investigation and research.

Gilead is committed to supporting innovative local research initiatives that ultimately improve patient care. As part of this commitment, the Gilead Australia Fellowship has established the Research Grants Program, enabling Australian researchers in HIV, chronic viral hepatitis, haematological oncology, NASH, inflammatory diseases and invasive fungal infections to apply for funding support for projects with a clinical and 'real-world' focus.

Gilead Australia is committed to supporting clinical research projects through the Research Grants Program

Funding support for local Australian research

Researchers in Australia currently face increasing competition for limited funding, particularly for projects with a local or community focus. In recognition of the impact such projects can have on patient care, and following a highly successful funding framework used in the UK and Europe, the Gilead Australia Fellowship: Research Grants Program aims to help bridge a gap in local Australian research funding.

The Research Grants Program will provide grants to support novel clinical research projects across Australia that can inform and shape best practice in patient care across the disease areas of HIV, chronic viral hepatitis, haematological oncology, NASH, inflammatory diseases and invasive fungal infections.


What is the focus of projects included in the Research Grants Program?

Applications that are successful in receiving funding from the Research Grants Program will be those ultimately focused on investigating solutions to improve outcomes for patients with HIV and/or chronic viral hepatitis, haematological malignancies, NASH, inflammatory diseases and invasive fungal infections. Projects may be based on sociological and epidemiological aspects of patient care in these three therapy areas, as well as practical aspects. A key focus for the judges is innovation, with projects driven by novel approaches particularly sought.

Research proposals are invited that explore and address the following issues and themes:


  • Developing and/or evaluating novel ways to prevent new HIV and/or chronic viral hepatitis infections
  • Improving community and primary care awareness, interest and uptake of screening to identify undiagnosed people with HIV and/or chronic viral hepatitis in high prevalence populations
  • Reducing late diagnosis of HIV and/or chronic viral hepatitis in high prevalence groups
  • Improving access, uptake and adherence to medication for HIV and/or chronic viral hepatitis, with emphasis on marginalised groups such as Indigenous communities, drug users and immigrants
  • Developing strategies to support the management of long-term complications associated with HIV and/or chronic viral hepatitis infection and its treatment
  • Identifying the reasons for and strategies to reduce loss to follow-up for patients with HIV and/or chronic viral hepatitis
  • Improving adherence to long-term medication through innovative programs.


  • Improving the care of patients with haematological malignancies


  • Understanding the application of new diagnostic, predictive and/or prognostic biomarkers in NASH
  • Improving the outcome of patients with advanced fibrosis due to NASH


  • Improving the care and outcomes of patients with:
  • Crohn’s disease
  • Ulcerative colitis
  • Sjogren’s syndrome
  • Lupus
  • Inflammatory arthropathies


  • Improving patient care quality and safety by investigating:
  • Antifungal resistance
  • Breakthrough fungal infections, including incidence, risk factors, populations at risk and management strategies
  • Optimisation of antifungal use and prevention of unnecessary exposure (potentially through implementation or use of appropriate diagnostics and/or stringent protocol management)
  • Development of start and stop criteria for antifungal therapy
  • Appropriate sequencing of antifungals

The Research Grants Program is unable to provide funding for basic research projects.

Who is eligible to apply for funding?

The Research Grants Program provides funding for clinical and academic staff at Australian hospitals, clinics, universities and research institutes, young investigators, nurses, GPs and other healthcare providers/researchers from professional organisations, in both urban and rural areas. Applications for community based projects that may not necessarily fall under traditional research grant criteria are welcome. The decision to fund a project will be made by an independent panel and is entirely unrelated to the use of any particular therapeutic agent.

How much funding is available for projects?

For the 2019 Research Grants Program, the total funding available is $250,000. The requested level of funding should be stated at the time of application, although the exact amount of funding allocated to each project may vary depending on the nature of the project. Funding is contingent on ethics approval being granted (if required), and all projects must be completed by the end of 2019.

Who is responsible for selecting the projects that will be awarded funding?

The applications will be reviewed by a judging panel made up of experts from across Australia recognised for their contributions to research as well as senior Australian public figures. In addition to the Panel, a member of Gilead senior management will be present at the judging sessions.

How are applications submitted to the Research Grants Program?

All applications and supporting documents must be submitted using the online form on the Gilead Australia Fellowship website ( Please see the Guidance for applicants page for more information.

What are the evaluation criteria?

All applications will be reviewed by the judging panel against clear criteria established to ensure balance and relevance (please see the Guidance for applicants page for more information). Each application should demonstrate the following:

  • Relevance to the research issues and themes
  • Feasibility of completing the project within the specified timelines
  • Sound scientific and research principles underpinning the potential for sustainability in shaping best practice.

What is the timeline for the 2019 Research Grants Program?

The website will open for applications on 11 June 2018 and close on 10 September 2018. Please see the Guidance for applicants page for more information.

Who can I contact for further information?

If you have any questions regarding the Research Grants Program, please contact

For more specific application queries, or if you would like to speak with someone in person to discuss your application, please contact the Medical Department at Gilead on 61 3 9272 4400.

For technical support please contact Gilead Client Services at

Please note that all queries must be directed as above and applicants may not contact the judges individually.